Original Research
Published on 21 Apr 2014
Erk5 is a mediator to TGFβ1-induced loss of phenotype and function in human podocytes
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2014.00071
- 6,487 views
- 15 citations